3 research outputs found
Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry
<p><b>Article full text</b></p>
<p><br></p>
<p>The full text of this article can
be found here<b>. </b><a href="https://link.springer.com/article/10.1007/s13555-017-0198-x">https://link.springer.com/article/10.1007/s13555-017-0198-x</a></p><p></p>
<p><br></p>
<p><b>Provide enhanced content for this
article</b></p>
<p><br></p>
<p>If you are an author of this
publication and would like to provide additional enhanced content for your
article then please contact <a href="http://www.medengine.com/Redeem/Ć¢ĀĀmailto:[email protected]Ć¢ĀĀ"><b>[email protected]</b></a>.</p>
<p><br></p>
<p>The journal offers a range of
additional features designed to increase visibility and readership. All
features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as āpeer reviewedā to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.</p>
<p><br></p>
<p>Other enhanced features include,
but are not limited to:</p>
<p><br></p>
<p>ā¢ Slide decks</p>
<p>ā¢ Videos and animations</p>
<p>ā¢ Audio abstracts</p>
<p>ā¢ Audio slides</p
Recommended from our members
Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and Analysts
<p></p><p><b>Article full text</b></p>
<p><br></p>
<p>The full text of this article can
be found here<b>. </b><a href="https://link.springer.com/article/10.1007/s13555-018-0242-5">https://link.springer.com/article/10.1007/s13555-018-0242-5</a></p><p></p><p></p><p>
</p><p><br></p>
<p><b>Provide enhanced content for this
article</b></p>
<p><br></p>
<p>If you are an author of this
publication and would like to provide additional enhanced content for your
article then please contact <a href="http://www.medengine.com/Redeem/Ć¢ĀĀmailto:[email protected]Ć¢ĀĀ"><b>[email protected]</b></a>.</p>
<p><br></p>
<p>The journal offers a range of
additional features designed to increase visibility and readership. All
features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as āpeer reviewedā to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.</p>
<p><br></p>
<p>Other enhanced features include,
but are not limited to:</p>
<p><br></p>
<p>ā¢ Slide decks</p>
<p>ā¢ Videos and animations</p>
<p>ā¢ Audio abstracts</p>
<p>ā¢ Audio slides</p><br><p></p
Supplemental Material - Predicting Psoriatic Arthritis in Psoriasis Patients ā A Swiss Registry Study
Supplemental Material for Predicting Psoriatic Arthritis in Psoriasis Patients ā A Swiss Registry Study by Mia-Louise Nielsen, Troels C. Petersen, Lara Valeska Maul, Jacob P. Thyssen, Simon F. Thomsen, Jashin J. Wu, Alexander A. Navarini, Thomas KĆ¼ndig, Nikhil Yawalkar, Christoph Schlapbach, Wolf-Henning Boehncke, Curdin Conrad, Antonio Cozzio, Raphael Micheroli, Lars Erik Kristensen, Alexander Egeberg, and Julia-Tatjana Maul in Journal of Psoriasis and Psoriatic ArthritisĀ®</p